Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132500) titled 'Predicting lymph node status after breast cancer treatment using CT imaging and artificial intelligence' on Sept. 15.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Yunnan Cancer Hospital
Condition:
Breast cancer with axillary lymph node metastasis
Intervention:
Gold Standard:Postoperative pathological evaluation of axillary lymph nodes. Patients undergo breast and axillary surgery after neoadjuvant therapy, with postoperative pathology as the gold standard. apCR is defined as postoperative pathological ypN0.
Recruitment Status: Not Recruiting
Phase: N/A
Date ...